MedPath
FDA Approval

BRAFTOVI

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Array BioPharma Inc.
DUNS: 004047838
Effective Date
July 28, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Encorafenib(50 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Finorga

Array BioPharma Inc.

640422218

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

BRAFTOVI

Product Details

NDC Product Code
70255-050
Route of Administration
ORAL
Effective Date
July 28, 2023
Code: 8L7891MRB6Class: ACTIBQuantity: 50 mg in 1 1
COPOVIDONE K25-31Inactive
Code: D9C330MD8BClass: IACT
POLOXAMER 188Inactive
Code: LQA7B6G8JGClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
SUCCINIC ACIDInactive
Code: AB6MNQ6J6LClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CROSPOVIDONE, UNSPECIFIEDInactive
Code: 2S7830E561Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327LClass: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
SHELLACInactive
Code: 46N107B71OClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
© Copyright 2025. All Rights Reserved by MedPath